🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This early phase IIA trial studies how well celecoxib, recombinant interfer...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2018-04-19
Trial ID
NCT03403634
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of Ampligen®...
Status
Completed
Location
Hope Clinical Research
Start Date
2023-06-30
Trial ID
NCT05592418
Treatments Being Tested
This is an open-label, prospective, randomized, controlled study of the saf...
Status
Terminated
Location
Orange County Center for Special Immunology
Start Date
2001-05
Trial ID
NCT00035581
Treatments Being Tested
This is a Phase I/II randomized study for subjects with recurrent ovarian, ...
Status
Terminated
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2011-04
Trial ID
NCT01312389
Treatments Being Tested
To evaluate ampligen at two dosage levels given twice weekly in combination...
Status
Completed
Location
Miami Veterans Administration Med Ctr
Start Date
TBD
Trial ID
NCT00002269
Treatments Being Tested
Determine the safety of a combination of IFN, celecoxib, and rintatolimod f...
Status
Terminated
Location
UPMC Hillman Cancer Center
Start Date
2012-10
Trial ID
NCT01545141
This phase II trial studies how well enteric-coated (EC) aspirin and rintat...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2019-11-29
Trial ID
NCT03899987
Treatments Being Tested
Pancreatic ductal adenocarcinoma (PDAC) is estimated to become the second l...
Status
Recruiting
Location
Erasmus MC
Start Date
2024-01-09
Trial ID
NCT05927142
Treatments Being Tested
This phase I/IIa trial studies the best dose and side effects of rintatolim...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2020-11-17
Trial ID
NCT04379518
Treatments Being Tested
This phase I/IIa trial tests the safety, side effects, and best dose of che...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2024-02-16
Trial ID
NCT05756166